Assessing the external validity of the VALIDATE-SWEDEHEART trial
Photo: Pixabay / Ben Kerckx The VALIDATE-SWEDEHEART trial was a registry-based randomized trial comparing bivalirudin and heparin in patients with acute myocardial infarction undergoing percutaneous coronary intervention. It showed no differences in mortality at 30 or 180 days. This study examines how well the trial population results may generalize to the population of all screened patients with
https://www.lupop.lu.se/article/assessing-external-validity-validate-swedeheart-trial - 2025-08-25